| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/13/2001 | EP1105419A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| 06/13/2001 | EP1105414A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 06/13/2001 | EP1105412A1 Serine protease inhibitors comprising alpha-keto heterocycles |
| 06/13/2001 | EP1105409A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 06/13/2001 | EP1105406A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 06/13/2001 | EP1105394A1 ISOXAZOLO 4,5-d]PYRIMIDINES AS CRF ANTAGONISTS |
| 06/13/2001 | EP1105393A1 Bicyclic piperidine and piperazine compounds having 5-ht 6? receptor affinity |
| 06/13/2001 | EP1105388A1 N-substituted azabicycloheptane derivatives, production and use thereof |
| 06/13/2001 | EP1105384A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 06/13/2001 | EP1105371A2 Novel aryl sulphonamide amino acid esters and analogues |
| 06/13/2001 | EP1105370A1 Novel aryl sulphonamides and analogues |
| 06/13/2001 | EP1105147A1 Methods for treatment of neurological disorders |
| 06/13/2001 | EP1105134A2 Nalmefene in combination with opioid analgesics |
| 06/13/2001 | EP1105132A1 The use of r(+)-g(a)-(2,3-dimethoxyphenyl)-1- 2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders |
| 06/13/2001 | EP1105131A2 Small molecule carbamates or ureas for vision and memory disorders |
| 06/13/2001 | EP1105129A1 Amelioration of apomorphine adverse effects |
| 06/13/2001 | EP1105126A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 06/13/2001 | EP1105125A2 Use of sulfonamides for treating vision and memory disorders |
| 06/13/2001 | EP1105124A2 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| 06/13/2001 | EP1105116A1 Hydroxamic acid derivatives as inhibitors of beta-amyloid production |
| 06/13/2001 | EP1105112A2 Compositions and uses for vision and memory disorders |
| 06/13/2001 | EP1105104A1 Extended release buccal bioadhesive tablet |
| 06/13/2001 | EP0888289B1 Anticonvulsant enantiomeric amino acid derivatives |
| 06/13/2001 | EP0863870B1 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents |
| 06/13/2001 | EP0842143B1 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives |
| 06/13/2001 | EP0807101B1 2-aminoindans as selective dopamine d3 ligands |
| 06/13/2001 | EP0805812B1 Bicyclic substituted hexahydrobenz(e)isoindole alpha-1- adrenergic antagonists |
| 06/13/2001 | EP0789776B1 Nucleic acid transfer system |
| 06/13/2001 | EP0781279B1 Quinoxalinedione nmda receptor antagonists |
| 06/13/2001 | EP0741722B1 Triazole derivatives |
| 06/13/2001 | EP0688331B1 New sulfated lyso-ganglioside derivatives |
| 06/13/2001 | EP0666858B1 5-arylindole derivatives and their use as serotonin (5-ht 1) agonists |
| 06/13/2001 | CN1299361A Hypnotic beta-carboline derivatives, process for their prepn. and their use as medicinal products |
| 06/13/2001 | CN1299357A Indole derivatives useful A.O. for the treatment of osteoporosis |
| 06/13/2001 | CN1299346A Ureas and carbamates of N-heterocyclic carboxylic acids and carboxylic acid isosteres |
| 06/13/2001 | CN1299342A Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
| 06/13/2001 | CN1299283A Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH |
| 06/13/2001 | CN1299279A Use of nicotinic receptor agonist |
| 06/13/2001 | CN1299276A CYP2A enzymes and their use in therapeutic and diagnostic method |
| 06/13/2001 | CN1298881A Solid, stable and concentrated type ortho-silicis acid complex based on bio-absorption, and its prepn. method |
| 06/13/2001 | CN1298710A Process for preparing exterior-applied plaster |
| 06/13/2001 | CN1298700A Brufen and its salts used for treating migraine method |
| 06/13/2001 | CN1067067C 杂环速激肽受体拮抗物 Heterocyclic tachykinin receptor antagonists |
| 06/13/2001 | CN1067057C Serotonin 5-HI1A and dopamin D2 receptor ligands |
| 06/13/2001 | CN1066959C Medicine for treating hydocephalus |
| 06/13/2001 | CN1066954C Decoction for treating mental diseases |
| 06/12/2001 | US6245916 Useful as neuropeptide y receptor ligands, anxiolytic agents, sedatives, and vasoconstrictors |
| 06/12/2001 | US6245820 Method for treating Meniere's disease |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
| 06/12/2001 | US6245802 Method for treating pain |
| 06/12/2001 | US6245801 Branched alkyl pyrrolidine-3-carboxylic acids |
| 06/12/2001 | US6245791 Use of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction |
| 06/12/2001 | US6245790 Oxazole compounds useful as PGE2 agonists and antagonists |
| 06/12/2001 | US6245783 Method of using neurotrophic sulfonamide compounds |
| 06/12/2001 | US6245780 Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression |
| 06/12/2001 | US6245778 1,6-naphthyridine anti-convulsants |
| 06/12/2001 | US6245777 Sodium channel modulators |
| 06/12/2001 | US6245776 Drug mixture of immune response modifier, fatty acid, preservative and carbomer |
| 06/12/2001 | US6245769 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disorders |
| 06/12/2001 | US6245766 Method of treating psychiatric conditions |
| 06/12/2001 | US6245765 Psychological disorders |
| 06/12/2001 | US6245748 Inhibition of an FGF-binding protein using ribozymes |
| 06/12/2001 | US6245736 Use of peptidic bradykinin antagonists for the treatment and prevention of Alzheimer's disease |
| 06/12/2001 | US6245357 Extended release dosage form |
| 06/12/2001 | US6245353 Mixing with effervescent base |
| 06/12/2001 | US6245330 Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF) |
| 06/12/2001 | CA2003388C Neuroprotective pharmaceutical compositions containing arylcyclohexylamines |
| 06/10/2001 | CA2327946A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/10/2001 | CA2327925A1 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/07/2001 | WO2001040521A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | WO2001040499A2 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 06/07/2001 | WO2001040457A1 Semaphorin receptor |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040316A1 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 06/07/2001 | WO2001040251A1 Transforming growth factor alpha hiii |
| 06/07/2001 | WO2001040249A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040246A1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 06/07/2001 | WO2001040245A1 N6 heterocyclic 5' modified adenosine derivatives |
| 06/07/2001 | WO2001040244A1 N6 heterocyclic 5' modified adenosine derivatives |
| 06/07/2001 | WO2001040243A2 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 06/07/2001 | WO2001040231A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 06/07/2001 | WO2001040230A1 Pyrazolopyrazines and their use as adenosine antagonists |
| 06/07/2001 | WO2001040226A1 Agents for improving learning or memory |
| 06/07/2001 | WO2001040217A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/07/2001 | WO2001040216A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | WO2001040215A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 06/07/2001 | WO2001040210A1 Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same |
| 06/07/2001 | WO2001040204A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 06/07/2001 | WO2001040187A2 Compound having effect of promoting neuron differentiation |
| 06/07/2001 | WO2001040185A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 06/07/2001 | WO2001039836A1 A rapid acting freeze dired oral pharmaceutical composition for treating migraine |
| 06/07/2001 | WO2001039804A2 Gd3 synthesis inhibitors for treating neuropathological disorders |
| 06/07/2001 | WO2001039796A2 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
| 06/07/2001 | WO2001039785A1 Formulation containing peanut leaf extract and its preparation |
| 06/07/2001 | WO2001039779A1 A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders |
| 06/07/2001 | WO2001039778A2 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans |
| 06/07/2001 | WO2001039777A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | WO2001039776A1 Combination of an ergoline and riluzole for preventing and treating motor neuron diseases |
| 06/07/2001 | WO2001039775A1 Benzimidazole compounds having nociceptin receptor affinity |
| 06/07/2001 | WO2001039772A1 Pharmaceutical formulations containing zolmitriptan |